Kenneth S. Cohen to Cyclophosphamide
This is a "connection" page, showing publications Kenneth S. Cohen has written about Cyclophosphamide.
Connection Strength
0.048
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.039
-
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant. 1998 Nov; 22(10):971-9.
Score: 0.009